Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02663362 · ClinicalTrials.gov registry record
Development and Validation of Multi-nuclear Magnetic Resonance Imaging and Spectroscopy for Whole Body Human Applications
A clinical trial of Human Body Composition and Human Body Function, sponsored by AdventHealth Translational Research Institute.
- Recruiting
- Registry status
- 250
- Enrollment target
- 1
- Study location
NCT02663362 is a study of Human Body Composition and Human Body Function that is actively recruiting participants, run by AdventHealth Translational Research Institute. The registered enrollment target is 250 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02663362, a study of Human Body Composition and Human Body Function, is actively recruiting participants, sponsored by AdventHealth Translational Research Institute.
- RECRUITING
- Registry status
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop and refine the techniques for using magnetic resonance imaging and magnetic resonance spectroscopy to understand the composition and function of the human body
Conditions Studied
Interventions
- OTHER To evaluate the reproducibility of acquiring multi-nuclear data on a new 3T Philips Magnet
Study Locations (1)
Florida
- Translational Research Institute for Metabolism and Diabetes - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2012-02 |
| Est. Completion | 2027-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02663362
The ClinicalTrials.gov registry entry for NCT02663362 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AdventHealth Translational Research Institute, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Human Body Composition appearing as the primary indexed condition, and to 1 intervention - of which To evaluate the reproducibility of acquiring multi-nuclear data on a new 3T Philips Magnet is the first listed.
NCT02663362 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT02663362 about?
NCT02663362 is a clinical study titled "Development and Validation of Multi-nuclear Magnetic Resonance Imaging and Spectroscopy for Whole Body Human Applications". The purpose of this study is to develop and refine the techniques for using magnetic resonance imaging and magnetic resonance spectroscopy to understand the composition and function of the human body
What is the current status of trial NCT02663362?
This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2012-02. Estimated completion is 2027-01.
What conditions does trial NCT02663362 study?
This clinical trial studies the following conditions: Human Body Composition, Human Body Function.
What interventions are being tested in trial NCT02663362?
The interventions under investigation include: To evaluate the reproducibility of acquiring multi-nuclear data on a new 3T Philips Magnet (OTHER).
Who is sponsoring clinical trial NCT02663362?
This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02663362 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.